Live Program Date: Wednesday, January 31, 2024
Program Number: 24EL-404

Educational Track: Technical/Clinical
Topics: Blood Donation & Collection, Patient Transfusion
Intended Audience: Directors, Hospital Blood Banks, Hospitals, Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Advanced, Basic, Intermediate

Faculty
(titles and affiliations at the time of the live program)
Director/Moderator: Elizabeth P. Crowe, MD, PhD, Assistant Professor, Department of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine; Medical Director, Blood Bank, Johns Hopkins Hospital, Baltimore, MD
Speakers: Baia Lasky, MD, Divisional Chief Medical Officer, Medical Director, Georgia and Alabama/Mississippi Regions, American Red Cross Biomedical Services, Douglasville, GA; Wen Lu, MD, Medical Director, Center for Regenerative Biotherapeutics, Transfusion Medicine Consultant, Mayo Clinic, Rochester, MN

Program Description
Apheresis-derived platelet units containing fewer platelets than the Food and Drug Administration (FDA)-required minimum (3.0 X10^11 platelets per unit) are labelled as "low-yield platelets." Given that platelet inventory shortages continue to be an ongoing challenge, implementation of low-yield platelets may increase the available platelet inventory and improve patient care; however, knowledge gaps persist with regard to the safety and efficacy of low yield platelets.

This lecture-format program will discuss the rationale and available evidence for low-yield platelets from the perspectives of a blood collection center and a hospital transfusion service. Further research is needed to better understand the benefits and limitations of low-yield platelets and optimize transfusion strategies in different patient populations.

Learning Objectives
After participating in this educational activity, participants should be able to:

Describe the concept of low-yield platelets and their significance in the blood supply chain.
Analyze the available evidence for safety and effectiveness of low-yield platelet transfusions.
Discuss strategies for effective implementation of low-yield platelets including patient selection criteria, inventory management, and tracking of transfusion outcomes.

How to Claim Continuing Education Credit

Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Baia Lasky MD

American Red Cross Biomedical Services

Appearances